SCHEMBL30396121

SCHEMBL30396121

COC(=O)c1cc2c(OC)cc(C(F)(F)F)cc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.45
GLA P06280 2/20 0.42
GAA P10253 1/20 0.42
CYP1A2 P05177 2/20 0.42
METAP2 P50579 2/20 0.42
NOTUM Q6P988 1/20 0.41
MPO P05164 1/20 0.40
XDH P47989 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
KIF11 P52732 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
NTSR1 P30989 1/20 0.39
RAB9A P51151 1/20 0.39
NCOA1 Q15788 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30396959 0.87 KDM4E (0.49) ABCG2CYP1A2METAP2KDM4EFLT3
SCHEMBL28603472 0.87 ULK1 (0.69) ULK1ABCG2CYP1A2METAP2NOTUM
SCHEMBL8198301 0.87 KDM4E (0.47) ABCG2GLAGAACYP1A2KMT2A
SCHEMBL23148079 0.84 NOTUM (0.46) ULK1CYP1A2NOTUMKIF11IDO1
SCHEMBL30396363 0.83 ULK1 (0.44) ULK1CYP1A2NOTUMKIF11MAPK1
SCHEMBL2504301 0.81 ULK1 (0.53) ULK1GLAGAACYP1A2XDH
SCHEMBL30310404 0.81 ULK1 (0.53) ULK1GLAGAACYP1A2XDH
SCHEMBL6223883 0.80 ULK1 (0.66) ULK1ABCG2GLAGAACYP1A2
SCHEMBL8349745 0.78 ULK1 (0.53) ULK1GLAGAACYP1A2KMT2A
SCHEMBL20494852 0.78 ULK1 (0.53) ULK1GLAGAACYP1A2XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096714-A Antiviral compounds for the treatment of coronavirus, picornavirus and norovirus infections 安力高医药股份有限公司 2023-05-09 CN disclosed
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 EP disclosed